CRISPR Therapeutics AG (CRSP) Balance Sheet Quarterly - Discounting Cash Flows
CRSP
CRISPR Therapeutics AG
CRSP (NASDAQ)
Period Ending: 2025 (Q3)
09-30
2025 (Q2)
06-30
2025 (Q1)
03-31
2024 (Q4)
12-31
2024 (Q3)
09-30
2024 (Q2)
06-30
2024 (Q1)
03-31
2023 (Q4)
12-31
2023 (Q3)
09-30
2023 (Q2)
06-30
2023 (Q1)
03-31
2022 (Q4)
12-31
2022 (Q3)
09-30
2022 (Q2)
06-30
2022 (Q1)
03-31
2021 (Q4)
12-31
2021 (Q3)
09-30
2021 (Q2)
06-30
2021 (Q1)
03-31
2020 (Q4)
12-31
2020 (Q3)
09-30
2020 (Q2)
06-30
2020 (Q1)
03-31
2019 (Q4)
12-31
2019 (Q3)
09-30
2019 (Q2)
06-30
2019 (Q1)
03-31
2018 (Q4)
12-31
2018 (Q3)
09-30
2018 (Q2)
06-30
2018 (Q1)
03-31
2017 (Q4)
12-31
2017 (Q3)
09-30
2017 (Q2)
06-30
2017 (Q1)
03-31
2016 (Q4)
12-31
2016 (Q3)
09-30
2016 (Q2)
06-30
2016 (Q1)
03-31
2015 (Q4)
12-31
Report Filing: 2025-11-10 2025-08-04 2025-05-06 2025-02-11 2024-11-05 2024-08-05
1234
Total Current Assets 1,929 1,734 1,868 1,937 1,944 2,010
1234
Cash and Short Term Investments 1,916 1,725 1,855 1,904 1,936 2,002
1234
Cash & Equivalents 286.5 197.1 235.2 298.3 225.7 484.5
1234
Short Term Investments 1,629 1,528 1,620 1,606 1,710 1,517
1234
Receivables 0 0 0 25 0 0
1234
Inventory 0 0 0 0 0 0
1234
Other Current Assets 13.38 8.91 12.33 8.31 8.25 8.79
1234
Total Assets 2,245 2,030 2,166 2,242 2,256 2,340
1234
Total Non-Current Assets 316.2 296 298.5 304.9 312.2 329.4
1234
Property, Plant and Equipment 255.5 262.6 269.7 277.6 284.8 291.6
1234
Goodwill and Intangible Assets 0 0 0 0 0 0
1234
Goodwill 0 0 0 0 0 0
1234
Intangible Assets 0 0 0 0 0 0
1234
Long Term Investments 28.41 30.61 0 0 0 11.22
1234
Deferred Tax Assets 0 0 0 0 0 0
1234
Other Long Term Assets 32.31 2.87 28.79 27.35 27.41 26.66
1234
Total Current Liabilities 119 104.4 119.4 87.78 89.81 127.8
1234
Accounts Payable 11.8 9.75 13.06 14.71 15.58 9.45
1234
Notes Payable/Short Term Debt 18.26 18.03 17.51 17.29 16.88 16.45
1234
Tax Payables 3.43 0.715 1.24 0.451 0.838 0.454
1234
Deferred Revenue 1.29 2.13 3.02 3.85 4.48 4.76
1234
Other Current Liabilities 84.18 73.74 84.61 51.49 52.03 96.71
1234
Total Liabilities 329.3 318.6 336.9 310 316.5 358.9
1234
Total Non-Current Liabilities 210.4 214.2 217.5 222.2 226.7 231.1
1234
Total Long Term Debt 192.8 197.4 201.9 206.4 210.7 214.9
1234
Deferred Tax Liabilities Non-Current 0 0 0 0 0 0
1234
Deferred Revenue Non-Current 12.32 12.32 12.32 12.32 12.32 12.58
1234
Capital Lease Obligations 192.8 197.4 201.9 206.4 210.7 214.9
1234
Other Long Term Liabilities -187.5 -192.9 -198.5 -203 -207 -211.2
1234
Total Equity 1,916 1,711 1,829 1,932 1,940 1,981
1234
Non-Controlling Interest 0 0 0 0 0 0
1234
Total Stockholders' Equity 1,916 1,711 1,829 1,932 1,940 1,981
1234
Retained Earnings -1,817 -1,710 -1,502 -1,366 -1,329 -1,243
1234
Accumulated Other Earnings 4.99 4.04 4.13 1.84 10.56 -2.88
1234
Common Stock 3.01 2.79 2.72 2.7 2.68 2.67
1234
Preferred Stock 0 0 0 0 0 0
1234
Additional Paid in Capital 3,725 3,415 3,324 3,293 3,255 3,224
1234
Total Liabilities & Total Equity 2,245 2,030 2,166 2,242 2,256 2,340
1234
Total Liabilities & Shareholders' Equity 2,245 2,030 2,166 2,242 2,256 2,340
1234
Total Investments 1,658 1,558 1,620 1,606 1,710 1,528
1234
Total Debt 211 215.5 219.4 223.7 227.5 231.3
1234
Net Debt -75.47 18.32 -15.83 -74.56 1.88 -253.2
1234
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program